Fear-motivated Behavior Induced by Prior Shock Experience is Mediated by Corticotropin-releasing Hormone Systems
Authors
Affiliations
In earlier studies, we established that in rats, antagonism of corticotropin-releasing hormone (CRH) receptors reduced the occurrence of fear-motivated behavior displayed immediately after administration of electric foot shock. Because exposure to stress is reported to have long-term behavioral and physiological effects, we examined whether central administration of the synthetic CRH receptor antagonist, alpha-helical CRH(9-41), would also alter fear-motivated behavioral and hormonal responses occurring 24 h after exposure to electric foot shock. Adult male rats were placed in a shock box and administered three, 1.0 mA foot shocks. Twenty-four hours later, rats received an intracerebroventricular infusion of 20 micrograms of alpha-helical CRH(9-41) or vehicle 20 min before re-exposure to the shock box. Antagonism of CRH receptors produced a significant reduction in fear-motivated freezing. However, stress-induced analgesia and plasma adrenocorticotropin concentrations did not differ significantly from vehicle-treated animals. In order to assess whether the reduction in freezing was due to intrinsic actions of the CRH receptor antagonist, non-shocked rats received central infusions of alpha-helical CRH(9-41) prior to re-exposure to the test box. Under these conditions, behavior exhibited by antagonist- and vehicle-treated rats did not differ significantly. Results suggest that the reduction in fear-motivated behavior is mediated by antagonism of endogenous CRH receptors and occurs independently of analgesic and hormonal reactions induced by prior exposure to stress.
PTSD and crime propensity: Stress systems, brain structures, and the nature of the relationship.
Svingen E Heliyon. 2023; 9(7):e18381.
PMID: 37519662 PMC: 10375856. DOI: 10.1016/j.heliyon.2023.e18381.
Michopoulos V, Norrholm S, Stevens J, Glover E, Rothbaum B, Gillespie C Psychoneuroendocrinology. 2017; 83:65-71.
PMID: 28595089 PMC: 5524593. DOI: 10.1016/j.psyneuen.2017.05.023.
Asok A, Schulkin J, Rosen J Psychoneuroendocrinology. 2016; 70:17-24.
PMID: 27153520 PMC: 4907900. DOI: 10.1016/j.psyneuen.2016.04.021.
Traits of fear resistance and susceptibility in an advanced intercross line.
McGuire J, Bergstrom H, Parker C, Le T, Morgan M, Tang H Eur J Neurosci. 2013; 38(9):3314-24.
PMID: 23968228 PMC: 5581004. DOI: 10.1111/ejn.12337.
Sink K, Walker D, Freeman S, Flandreau E, Ressler K, Davis M Mol Psychiatry. 2012; 18(3):308-19.
PMID: 22290119 PMC: 3578178. DOI: 10.1038/mp.2011.188.